These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence. Rahardjo D, Kamil ST, Pakasi LS. Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211 [Abstract] [Full Text] [Related]
7. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density. Men S, Cakar B, Conkbayir I, Hekimoglu B. J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539 [Abstract] [Full Text] [Related]
8. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Bretton PR, Evans WP, Borden JD, Castellanos RD. Cancer; 1994 Dec 01; 74(11):2991-5. PubMed ID: 7525040 [Abstract] [Full Text] [Related]
10. Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer? Ohori M, Dunn JK, Scardino PT. Urology; 1995 Nov 01; 46(5):666-71. PubMed ID: 7495118 [Abstract] [Full Text] [Related]
11. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density. Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Urology; 1995 Dec 01; 46(6):779-84. PubMed ID: 7502415 [Abstract] [Full Text] [Related]
13. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density. Benson MC, McMahon DJ, Cooner WH, Olsson CA. World J Urol; 1993 Dec 01; 11(4):206-13. PubMed ID: 7508785 [Abstract] [Full Text] [Related]
14. Value of prostate volume measurement using transabdominal ultrasonography for the improvement of prostate-speci fi c antigen-based cancer detection. Kobayashi T, Kawahara T, Nishizawa K, Ogura K, Mitsumori K, Ide Y. Int J Urol; 2005 Oct 01; 12(10):881-5. PubMed ID: 16323981 [Abstract] [Full Text] [Related]
15. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases. Aksoy Y, Oral A, Aksoy H, Demirel A, Akcay F. Ann Clin Lab Sci; 2003 Oct 01; 33(3):320-3. PubMed ID: 12956448 [Abstract] [Full Text] [Related]
16. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer]. Iwaki H, Kajita Y, Shimizu Y, Yamauchi T. Hinyokika Kiyo; 2001 Mar 01; 47(3):169-74. PubMed ID: 11329957 [Abstract] [Full Text] [Related]
17. The usefulness of prostate-specific antigen (PSA) density in patients with intermediate serum PSA level in a country with low incidence of prostate cancer. Yu HJ, Lai MK. Urology; 1998 May 01; 51(5A Suppl):125-30. PubMed ID: 9610567 [Abstract] [Full Text] [Related]
18. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen]. Schmid HP, Ravery V, Toublanc M, Boccon-Gibod L. Schweiz Med Wochenschr; 1996 Sep 07; 126(36):1530-5. PubMed ID: 8927956 [Abstract] [Full Text] [Related]